Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CI-1029 is an HIV protease inhibitor that is effective against mutant HIV proteases and drug-resistant HIV strains. It has excellent protease activity, good antiviral efficacy in cell tests, and has good bioavailability in a variety of animal species.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 2,870.00 | |
50 mg | 10-14 weeks | $ 3,780.00 | |
100 mg | 10-14 weeks | $ 5,200.00 |
Description | CI-1029 is an HIV protease inhibitor that is effective against mutant HIV proteases and drug-resistant HIV strains. It has excellent protease activity, good antiviral efficacy in cell tests, and has good bioavailability in a variety of animal species. |
Synonyms | CI1029, PD 178390, UNII-VDH375TRL9, PD178390 |
Molecular Weight | 483.66 |
Formula | C28H37NO4S |
CAS No. | 207736-05-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CI-1029 207736-05-8 CI1029 PD 178390 UNII-VDH375TRL9 CI 1029 PD178390 PD-178390 inhibitor inhibit